HWAM
EBS icon

Hennion & Walsh Asset Management’s Emergent Biosolutions EBS Stock Holding History

Hennion & Walsh Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18,196
Closed -$565K – 779
2022
Q2 		$565K Sell
18,196
-462
-2% -$15.8K 0.04% 460
2022
Q1 		$766K Sell
18,658
-15,376
-45% -$678K 0.04% 406
2021
Q4 		$1.48M Sell
34,034
-18,475
-35% -$836K 0.07% 282
2021
Q3 		$2.63M Sell
52,509
-510
-1% -$30.9K 0.14% 209
2021
Q2 		$3.34M Sell
53,019
-13,275
-20% -$853K 0.18% 159
2021
Q1 		$6.16M Buy
+66,294
New +$6.79M 0.37% 66

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Hennion & Walsh Asset Management's EBS Position: Q3 2022 in Review

Hennion & Walsh Asset Management sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 18,196 shares — an estimated $565K sold.

Hennion & Walsh Asset Management first reported a position in EBS in Q1 2021 and held it in 6 quarters. The position peaked at $6.16M in Q1 2021. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • Hennion & Walsh Asset Management reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 18,196 Emergent Biosolutions shares in Q3 2022, an estimated $565K.
  • Hennion & Walsh Asset Management first reported a position in Emergent Biosolutions in Q1 2021 and held it in 6 quarters.
  • Hennion & Walsh Asset Management's Emergent Biosolutions position peaked at $6.16M in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.